Blood Group Typing Market Share Analysis, Growth Forecast

Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typingmarket has witnessed significant growth due to the advancement in technology which has improved detection methods.
Blood group typing can be done via various tests namely, antigen typing, cross-matching tests, antibody screening, human leukocyte antigen (HLA) typing and ABO blood tests. Among the different blood group typing tests, antibody screening is expected to witness the fastest growth in the global market during the forecast period. Rising demand for early disease diagnosis and increase in chronic disorder cases is causing the growth in the usage of the antibody screening test for blood group typing.




Globally, the demand for blood group typing products and services was largest in hospitals due to the increasing awareness regarding the importance of blood donations and growth in the requirements of blood for surgical treatments. Other key end users in the global blood group typing market are clinical laboratories and blood banks.
The global blood group typing market is expected to grow significantly during the forecast period. The major driving force behind this growth are the increase in the use of blood group typing in forensic science; need for grouping of the blood during pregnancy and prenatal testing; growth in the number of road accidents and trauma cases that requires blood transfusion; increase in the demand of blood and blood products; and rise in blood donation. Blood group typing is very crucial for the detection of hemolytic disease of the newborn (HDN) in pregnant women which eventually stimulates the usage of blood group typing, hence causing the growth of the global market.

They key players in the global blood group typing market are Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, BAG Health Care GmbH, DAY medical SA, Grifols S.A., Ortho Clinical Diagnostics, Inc., Novacyt Group, DIAGAST, AXO Science, and Agena Bioscience, Inc.
In October 2016, Bio-Rad Laboratories, Inc., a manufacturer of life sciences and clinical diagnostic products, received the U.S. Food and Drug Administration (FDA) approval for its IH-1000 blood instrument.
In May 2014, Immucor’s PreciseType HEA Test received FDA approval to be used for screening blood donors for sickle cell trait (SCT). The PreciseType HEA test is the FDA-approved molecular assay designed to provide blood banks and clinicians with the detailed genetic matching information that they need to reduce the risk of alloimmunization and serious haemolytic reactions, which is especially problematic for patients receiving frequent blood transfusions.
Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Connect with us: LinkedIn | Twitter | Google + | Facebook

Comments

Popular posts from this blog

How is Booming Life Sciences Sector Contributing to Growth of Saudi Microbiology Cell Culture Market?

Government and International Organizations Investing Heavily in Synthetic Biology

How is Increasing Focus on Personalized Medicine Driving Cancer/Tumor Profiling Market?